€8.34
0.24% yesterday
Xetra, Aug 08, 05:36 pm CET
ISIN
DE0005157101
Symbol
HNL
Index

Dr. Hönle Stock price

€8.34
-0.98 10.52% 1M
-2.46 22.78% 6M
+0.84 11.20% YTD
-7.56 47.55% 1Y
-17.16 67.29% 3Y
-34.56 80.56% 5Y
-18.01 68.35% 10Y
-0.77 8.45% 20Y
Xetra, Closing price Fri, Aug 08 2025
-0.02 0.24%
ISIN
DE0005157101
Symbol
HNL
Index
Sector

Key metrics

Basic
Market capitalization
€50.7m
Enterprise Value
€97.7m
Net debt
€47.0m
Cash
€5.5m
Shares outstanding
6.1m
Valuation (TTM | estimate)
P/E
negative | 82.6
P/S
0.5 | 0.5
EV/Sales
1.0 | 1.0
EV/FCF
53.1
P/B
0.6
Dividends
DPS
€0.00
Yield 1Y | 5Y
0.0% | 0.4%
Growth 1Y | 5Y
- | -100.0%
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€97.8m | €101.1m
EBITDA
€3.4m | €7.6m
EBIT
€-9.8m | €2.2m
Net Income
€-13.0m | €610.0k
Free Cash Flow
€1.8m
Growth (TTM | estimate)
Revenue
-3.1% | 2.4%
EBITDA
194.4% | 98.8%
EBIT
24.8% | 228.5%
Net Income
9.6% | 104.6%
Free Cash Flow
-37.0%
Margin (TTM | estimate)
Gross
59.5%
EBITDA
3.5% | 7.5%
EBIT
-10.1%
Net
-13.2% | 0.6%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
51.1%
Return on Equity
-16.7%
ROCE
-8.1%
ROIC
-8.0%
Debt/Equity
0.7
More
EPS
€-2.1
FCF per Share
€0.3
Short interest
-
Employees
585
Rev per Employee
€170.0k
Show more

Is Dr. Hönle a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Dr. Hönle Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Dr. Hönle forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Dr. Hönle forecast:

Buy
83%
Hold
17%

Financial data from Dr. Hönle

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
98 98
3% 3%
100%
- Direct Costs 40 40
22% 22%
41%
58 58
17% 17%
59%
- Selling and Administrative Expenses 42 42
4% 4%
43%
- Research and Development Expense - -
-
-
3.37 3.37
194% 194%
3%
- Depreciation and Amortization 13 13
39% 39%
14%
EBIT (Operating Income) EBIT -9.85 -9.85
25% 25%
-10%
Net Profit -13 -13
10% 10%
-13%

In millions EUR.

Don't miss a Thing! We will send you all news about Dr. Hönle directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Dr. Hönle Stock News

AD HOC NEWS
3 days ago
Dr. Hönle AG / DE0005157101
AD HOC NEWS
5 days ago
Dr. Hönle AG / DE0005157101
AD HOC NEWS
3 months ago
Dr. Hönle AG / DE0005157101
More Dr. Hönle News

Company Profile

Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. It operates through the following segments: Equipment and Systems; Adhesives; and Glass and Lamps. The Equipment and Systems offers UV products that are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Adhesive segment includes industrial adhesives for a spectrum of applications. The Glass and Lamp segment comprises quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries as well as lamps for water sterilization and drying of coatings and adhesives. The company was founded by Karl Hönle and Günter Schmid in 1976 and is headquartered in Graefelfing, Germany.

Head office Germany
CEO Markus Arendt
Employees 585
Founded 1976
Website www.hoenle.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today